Infantile hemangioma research: Looking backward and forward

Journal of Investigative Dermatology

Volumn 131, Issue 12, 2011, Pages 2345-2348

  Frieden, Ilona J ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ACEBUTOLOL; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CORTICOSTEROID; NADOLOL; PROPRANOLOL; RAPAMYCIN; TIMOLOL;

CANCER INHIBITION; CANCER RESEARCH; CAPILLARY HEMANGIOMA; CELL RENEWAL; CORTICOSTEROID THERAPY; DRUG EFFICACY; DRUG MECHANISM; DRUG POTENCY; HUMAN; PRIORITY JOURNAL; REVIEW; SYSTEMIC THERAPY; TOPICAL TREATMENT; TUMOR GROWTH; UNSPECIFIED SIDE EFFECT;

EID: 80855128838     PISSN: 0022202X     EISSN: 15231747     Source Type: Journal    
DOI: 10.1038/jid.2011.315     Document Type: Note

References (20)

1. Blatt J, Stavas J, Moats-Staats B et al. (2010) Treatment of childhood kaposiform hemangioendothelioma with sirolimus. Pediatr Blood Cancer 55:1396-8
2. Boscolo E, Bischoff J (2009) Vasculogenesis in infantile hemangioma. Angiogenesis 12:197-207
3. Chang LC, Haggstrom AN, Drolet BA et al. (2008) Growth characteristics of infantile hemangiomas: implications for management. Pediatrics 122:360-7
4. Chiller KG, Passaro D, Frieden IJ (2002) Hemangiomas of infancy: clinical characteristics, morphologic subtypes, and their relationship to race, ethnicity, and sex. Arch Dermatol 138:1567-76 (Pubitemid 35453469)
5. Dadras SS, North PE, Bertoncini J et al. (2004) Infantile hemangiomas are arrested in an early developmental vascular differentiation state. Mod Pathol 17:1068-79 (Pubitemid 39128233)
6. Ezekowitz RA, Mulliken JB, Folkman J (1992) Interferon alfa-2a therapy for life-threatening hemangiomas of infancy. N Engl J Med 326:1456-63
7. Greenberger S, Yuan S, Walsh LA et al. (2011) Rapamycin suppresses self-renewal and vasculogenic potential of stem cells isolated from infantile hemangioma. J Invest Dermatol 131:2467-76
8. Haggstrom AN, Drolet BA, Baselga E et al. (2006a) Prospective study of infantile hemangiomas: clinical characteristics predicting complications and treatment. Pediatrics 118:882-7 (Pubitemid 46091612)
9. Haggstrom AN, Lammer EJ, Schneider RA et al. (2006b) Patterns of infantile hemangiomas: new clues to hemangioma pathogenesis and embryonic facial development. Pediatrics 117:698-703 (Pubitemid 46063211)
10. Itinteang T, Tan ST, Brasch H et al. (2010) Haemogenic endothelium in infantile haemangioma. J Clin Pathol 63:982-6
11. Jinnin M, Medici D, Park L et al. (2008) Suppressed NFAT-dependent VEGFR1 expression and constitutive VEGFR2 signaling in infantile hemangioma. Nat Med 14:1236-46
12. Khan ZA, Boscolo E, Picard A et al. (2008) Multipotential stem cells recapitulate human infantile hemangioma in immunodeficient mice. J Clin Invest 118:2592-9 (Pubitemid 351949786)
13. Kleinman ME, Greives MR, Churgin SS et al. (2007) Hypoxia-induced mediators of stem/progenitor cell trafficking are increased in children with hemangioma. Arterioscler Thromb Vasc Biol 27:2664-70 (Pubitemid 350158920)
14. Leaute-Labreze C, Dumas De La Roque E, Hubiche T et al. (2008) Propranolol for severe hemangiomas of infancy. N Engl J Med 358:2649-51 (Pubitemid 351831393)
15. Leonardi-Bee J, Batta K, O'Brien C et al. (2011) Interventions for infantile haemangiomas (strawberry birthmarks) of the skin. Cochrane Database Syst Rev 5:CD006545
16. Mulliken JB, Glowacki J (1982) Hemangiomas and vascular malformations in infants and children: a classification based on endothelial characteristics. Plast Reconstr Surg 69:412-22 (Pubitemid 12191292)
17. Mulliken JB, Young AE (1988) Treatment of hemangiomas. In: Mcallister L (ed) Vascular Birthmarks: Hemangiomas and Malformations. WB Saunders: Philadelphia, PA. pp77-103
18. North PE, Waner M, Mizeracki A et al. (2000) GLUT1: a newly discovered immunohistochemical marker for juvenile hemangiomas. Hum Pathol 31:11-22 (Pubitemid 30054381)
19. Tan ST, Hasan Q, Velickovic M et al. (2000) A novel in vitro human model of hemangioma. Mod Pathol 13:92-9 (Pubitemid 30077909)
20. Waner M, North PE, Scherer KA et al. (2003) The nonrandom distribution of facial hemangiomas. Arch Dermatol 139:869-75 (Pubitemid 36898921)